Esperion Therapeutics Inc...
2.16
-0.08 (-3.57%)
At close: Jan 15, 2025, 12:35 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY02 FY01 FY00 FY99
Cash & Equivalents 82.25M 124.78M 208.89M 304.96M 166.13M 36.97M 34.47M 38.16M 77.34M 85.04M 56.54M 6.51M 1.57M 40.50M 70.29M 70.23M 5.90M
Short-Term Investments n/a 42.09M 50.44M n/a 34.65M 99.05M 165.73M 173.42M 134.93M 20.80M 3.53M n/a n/a 4.35M n/a n/a n/a
Long-Term Investments n/a 42.09M 50.44M n/a 34.65M 99.29M 239.15M 204.32M 215.24M 56.54M 17.54M n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a -42.09M 50.00M -7.36M -34.65M -99.05M -165.73M -173.42M -134.93M -20.80M n/a -174.03K 10.35K 35.00K 633.00K 534.00K n/a
Receivables 48.49M 33.73M 22.93M 12.39M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory 65.62M 35.20M 34.39M 16.14M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 4.70M 10.89M 12.31M 12.41M 10.93M 6.61M 3.73M 1.99M 2.13M 858.00K 919.51K 367.22K 292.96K 410.00K 1.00M 1.11M 139.00K
Total Current Assets 201.06M 246.68M 328.97M 345.90M 211.71M 142.63M 203.92M 213.58M 214.39M 106.77M 60.62M 7.14M 1.86M 45.26M 71.29M 71.34M 6.04M
Property-Plant & Equipment 4.67M 1.20M 2.56M 7.31M 2.68M 520.00K 435.00K 674.00K 807.00K 780.00K 80.81K 120.21K 251.53K 3.00M 3.31M 2.50M 1.96M
Goodwill & Intangibles 56.00K 56.00K 56.00K 56.00K 56.00K 56.00K 56.00K 56.00K 56.00K 56.00K 55.74K 53.83K 53.83K 3.11M 3.11M 3.50M n/a
Total Long-Term Assets 4.73M 1.26M 52.62M 7.36M 2.73M 819.00K 73.91M 31.64M 81.18M 36.58M 17.67M 174.03K 315.70K 6.14M 7.05M 6.54M 1.96M
Total Assets 205.80M 247.94M 381.59M 353.26M 214.45M 143.45M 277.83M 245.21M 295.57M 143.34M 78.29M 7.31M 2.18M 51.41M 78.34M 77.88M 8.00M
Account Payables 31.72M 23.04M 17.56M 51.98M 28.86M 44.89M 20.38M 4.59M 707.00K 2.04M 2.23M 476.28K 691.18K 1.69M 2.92M 3.94M 1.43M
Deferred Revenue 25.40M 3.51M 5.68M 1.66M 2.15M n/a 38.00K 40.00K 37.00K 107.00K n/a 1.19M n/a n/a n/a n/a n/a
Short-Term Debt 36.38M 25.14M 12.69M 7.98M 5.69M n/a 1.04M 1.71M 1.60M 638.00K n/a 15.24M n/a 1.06M 863.00K 697.00K 495.00K
Other Current Liabilities 62.72M 40.62M 37.42M 37.84M 34.58M 19.40M 11.69M 9.24M 3.28M 2.71M 1.88M 1.44M 644.83K 2.19M 2.57M 2.53M 980.38K
Total Current Liabilities 156.22M 92.31M 73.35M 94.07M 66.08M 64.33M 33.14M 15.59M 5.63M 5.49M 4.20M 17.17M 1.34M 4.93M 6.36M 7.16M 2.90M
Long-Term Debt 504.57M 260.56M 258.80M 182.82M 1.11M n/a n/a 1.02M 2.69M 4.30M n/a 7.53M 6.90M 7.73M 5.48M 3.03M 2.28M
Other Long-Term Liabilities n/a 218.84M 245.74M 172.50M 127.31M n/a n/a n/a n/a n/a n/a n/a n/a -7.73M -5.48M -3.03M -219
Total Long-Term Liabilities 504.57M 479.41M 505.18M 355.32M 128.42M n/a n/a 1.02M 2.69M 4.30M n/a 7.53M 6.90M 7.73M 5.48M 3.03M 2.28M
Total Liabilities 660.79M 571.72M 578.53M 449.39M 194.50M 64.33M 33.14M 16.61M 8.31M 9.79M 4.20M 24.70M 8.24M 12.66M 11.84M 10.19M 5.18M
Total Debt 540.95M 260.95M 260.20M 185.41M 1.56M n/a 1.04M 2.73M 4.29M 4.94M n/a 22.77M 6.90M 8.79M 6.34M 3.72M 2.78M
Common Stock 118.00K 75.00K 61.00K 26.00K 27.00K 27.00K 26.00K 23.00K 23.00K 20.00K 15.36K 346.00 308.00 29.00K 29.00K 26.00K 1.94K
Retained Earnings -1.55B -1.34B -1.11B -838.82M -695.27M -598.10M -396.29M -229.20M -154.22M -104.44M -68.06M -41.98M -30.23M -94.05M -65.32M -40.39M -12.81M
Comprehensive Income n/a -2.00K -31.00K 0.00 23.00K -319.00K -845.00K -172.00K -482.00K -59.00K -3.03K -1.17M -1.04M -3.69M -2.42M -1.26M -471.62K
Shareholders Equity -454.99M -1.34B -1.11B -838.82M -695.27M -598.10M 244.69M 228.60M 287.26M 133.55M 74.09M -17.39M -6.06M 38.74M 66.50M 67.69M 2.81M
Total Investments n/a 84.17M 100.88M n/a 69.30M 99.29M 239.15M 204.32M 215.24M 56.54M 21.06M n/a n/a 4.35M n/a n/a n/a